≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    5-Amino-1MQ research peptide - high purity lyophilized powder for laboratory research

    10MG

    $55
    3ml Vial
    In Stock
    Bulk Discounts

    Buy 3+ for $52.25 each and save 5%

    Buy 5+ for $49.50 each and save 10%

    Buy 10+ for $46.75 each and save 15%

    This product is for research purposes only. Not for human consumption.

    Purity: >98% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: C11H12N4O

    Molecular Weight: 216.24 g/mol

    CAS Number: 42464-96-0

    PubChem CID: N/A

    5-Amino-1MQ

    Metabolic

    Overview

    5-Amino-1MQ (5-amino-1-methylquinolinium iodide, chemical formula C11H13N2+I−) is a small molecule compound that functions as a selective, competitive inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme that catalyzes the methylation of nicotinamide (a form of vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor, producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine.

    The compound's mechanism of action is understood to involve increasing intracellular NAD+ levels by preventing nicotinamide consumption by NNMT. This may affect sirtuin activity, mitochondrial function, and fatty acid oxidation. It has also been associated with the 'browning' of white adipose tissue, a process where energy-storing white fat cells adopt characteristics of metabolically active brown adipocytes.

    Mechanism of Action

    5-Amino-1MQ exerts its effects primarily through the competitive inhibition of nicotinamide N-methyltransferase (NNMT). This enzyme is expressed in multiple tissues including liver, adipose tissue, skeletal muscle, and kidney. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide and S-adenosylhomocysteine (SAH). The activity of NNMT has been shown to have consequences for cellular metabolism through several interconnected mechanisms.

    NAD+ Preservation and Sirtuin Activation

    NNMT activity consumes nicotinamide, a key precursor for NAD+ biosynthesis via the salvage pathway. By methylating nicotinamide, NNMT can reduce the availability of this precursor, leading to lower intracellular NAD+ levels. NAD+ is a critical coenzyme in cellular redox reactions and a substrate for enzymes including sirtuins, PARPs, and CD38.

    By inhibiting NNMT, 5-Amino-1MQ allows nicotinamide to be available for NAD+ synthesis, which can lead to increased intracellular NAD+ concentrations. Elevated NAD+ may in turn activate sirtuins, such as SIRT1 in adipocytes and hepatocytes. Sirtuin activation can influence metabolic regulatory proteins like PGC-1α, a regulator of mitochondrial biogenesis and oxidative metabolism.

    Methylation Capacity

    NNMT inhibition also affects the cellular methylation cycle. NNMT consumes SAM, the universal methyl donor, and produces SAH, an inhibitor of many methyltransferases. Inhibiting NNMT may alter the intracellular SAM/SAH ratio, which can influence the activity of other SAM-dependent methylation reactions involving DNA, histones, and other proteins.

    Browning of White Adipose Tissue

    NNMT inhibition has been observed to promote the 'browning' of white adipose tissue, where white adipocytes acquire features of beige/brown adipocytes, which have numerous mitochondria and express uncoupling protein 1 (UCP1). This process can lead to the dissipation of energy as heat through non-shivering thermogenesis. The browning effect may be mediated through pathways involving SIRT1/PGC-1α activation and increased expression of thermogenic genes.

    Effects on Glucose Metabolism

    NNMT inhibition has been observed to affect insulin sensitivity and glucose metabolism in research models. This may occur through mechanisms including increased NAD+ levels, sirtuin activity, and altered mitochondrial function. In some studies, NNMT inhibition appeared to reduce hepatic triglyceride content by affecting hepatic fatty acid oxidation.

    The NNMT product, 1-methylnicotinamide, may also have biological activities, and reducing its production may contribute to the observed metabolic changes.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • Metabolic pathway studies
    • NAD+ metabolism research
    • Mitochondrial function studies
    • Energy expenditure research
    • Adipose tissue biology studies

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.